Arcadia Biosciences Welcomes Lilian Shackelford Murray to Its Board of Directors Arcadia Biosciences Welcomes Lilian Shackelford Murray to Its Board of Directors
~ Experienced financial advisor and investment fund manager was an early investor in company’s key development technology ~ Arcadia Biosciences, Inc.,... Arcadia Biosciences Welcomes Lilian Shackelford Murray to Its Board of Directors

~ Experienced financial advisor and investment fund manager was an early investor in company’s key development technology ~

Arcadia Biosciences, Inc., an agricultural food ingredient company, announced that Lilian Shackelford Murray, an investment fund manager, has joined its board of directors. Murray was elected at the company’s annual stockholders meeting and replaces Uday Garg of Mandala Capital. Amy Yoder, CEO of Anuvia Plant Nutrients, was also re-elected to the board at the meeting.

Murray has more than 33 years of financial and management experience as a financial advisor, investment banker and managing director in the biotech and healthcare industries. She is the founder and manager of Dovedale Investments, a money management firm investing in emerging market exchange traded funds. Murray is also a managing member of Saints Capital V, where she provides investment fund management services. She previously served as a managing director and senior healthcare banker at Prudential Volpe Technology Group and its predecessor, Volpe, Brown Whelan. Prior to Volpe, Murray was a managing director and co-head of healthcare investment banking for Wheat First Securities and a senior vice president at Dean Witter Reynolds. She received an MBA from Harvard Business School and a BS from the University of Virginia.

Murray served as an observer to the Arcadia board from March 2007 until May 2015. Her prior board experience also includes service as a director of eMedicine.com, Inc., Extended Care Information Network, Inc. and LifeMasters Supported SelfCare, Inc.

“Lilian was an early investor in the TILLING technology that underpins Arcadia’s non-GM health and nutrition portfolio,” said Kevin Comcowich, chair of Arcadia’s board of directors. “She has been a strong supporter of the company for many years, and her financial and investment experience will be a welcome addition to the board. I would also like to thank Uday Garg for his service and contributions to the board.”

“I have been impressed with the innovation and breadth of technologies at Arcadia,” said Murray. “These products have the potential to provide consumer health benefits and agricultural efficiency worldwide, and I look forward to working with the company to deliver value to growers, food manufacturers and consumers.”

No comments so far.

Be first to leave comment below.

Your email address will not be published. Required fields are marked *

analytics.js